J&J Fights For Judgment In Drug Pricing Suit
Johnson & Johnson has rejected a bid by plaintiffs in the massive antitrust class action over the alleged artificial inflation of the prices of various prescription medications to decide whether to...To view the full article, register now.
Already a subscriber? Click here to view full article